Effect of synbiotic supplement on placental uterine blood flow in patients with polycystic ovary syndrome
Phase 3
- Conditions
- Polycystic ovary syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20191104045328N17
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 98
Inclusion Criteria
Pregnant mothers of 28 and 37 weeks of pregnancy with polycystic ovaries referred to Arak Taleghani Hospital.
Age 18-50 years
Consent to participate in the study
Exclusion Criteria
History of congenital disease
History of chronic diseases such as diabetes, cancer, high blood pressure, liver or kidney failure, etc.
History of intrauterine growth restriction or preeclampsia or pregnancy complications in previous pregnancies
Having a special diet or taking anti-inflammatory and sugar-lowering supplements in the last 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method